Cna Financial Corp

CNA Financial maintains a conservative capital structure with a debt-to-equity ratio of 0.27 and a price-to-book multiple of 1.19. The balance sheet shows total assets of $69.87 billion against total liabilities of $58.69 billion, resulting in total equity of $11.19 billion. Liquidity is assessed as medium risk, with the company holding no short-term debt and carrying $2.97 billion in long-term debt. Operating cash flow stands at $1.04 billion, while free cash flow is $1.01 billion, indicating strong cash generation relative to capital expenditures of $33 million.

Profitability metrics show a return on equity of 11.42% and a return on assets of 1.83%. The company reported net income of $532 million on revenue of $741 million for the period, reflecting a high net margin. The price-to-earnings ratio is 10.3, suggesting the market values the earnings stream at a moderate multiple. Without specific cohort median data provided in the input, direct comparative analysis against sector peers is omitted, but the internal returns indicate efficient capital utilization.

Revenue concentration and geographic exposure details are not present in the available data. The company operates as a multiline insurer, but specific segment breakdowns or regional revenue mixes are not disclosed in the current snapshot. Consequently, claims regarding customer or geographic concentration risk cannot be substantiated with the provided figures.

Growth trajectory analysis is limited by the absence of historical period data. The current financial snapshot provides a single-period view of revenue and net income. Without five-year annual or eight-quarter quarterly trends, it is not possible to assess the directionality of revenue growth or earnings stability over time.

Risk assessment highlights medium liquidity and medium dilution risks. Key flags indicate that net cash is negative after subtracting total debt, and source documents mention dilution or offering risk. The company faces potential material adverse effects from catastrophic events and competitive pressure from insurers offering lower-priced products. These factors contribute to the medium risk ratings assigned to liquidity and dilution.

Recent events include an 8-K filing with material items under code 2.02, indicating a change in executive leadership or corporate governance. Analyst sentiment is neutral, with a mean recommendation of 3.00 (Hold) and a mean price target of $37.69, which is below the current market price of $48.39. The high price target is $61.75, while the low is $15.00, reflecting a wide dispersion in analyst views.

Free cash flow reached $2.4 billion in FY2025, reflecting strong cash generation capabilities despite revenue fluctuations.

The company maintains a low leverage band with a debt-to-equity ratio of 0.26, ensuring financial stability.

Cash conversion ratio of 1.95 is above the cohort median of 1.23, highlighting superior cash flow efficiency.

Net income declined by 25% year-over-year in FY2025, signaling significant earnings volatility and potential deterioration.

Revenue contracted by 0.5% annually over the two-year period from FY2023 to FY2025, showing top-line weakness.

The company faces medium dilution risk and medium liquidity risk, posing potential threats to shareholder value.

Long-term debt increased to $2.97 billion in FY2025, up from $2.48 billion in FY2023, raising leverage concerns.

Revenue $741.0M; Net margin 71.8%.

• ▍Revenue $741.0M
• ▍Net margin 71.8%

Revenue $374.0M; Net margin 56.4%.

• ▍Revenue $374.0M
• ▍Net margin 56.4%

Revenue $1.58B; Net margin 81.0%.

• ▍Revenue $1.58B
• ▍Net margin 81.0%

Revenue $1.61B; Net margin 59.6%.

• ▍Revenue $1.61B
• ▍Net margin 59.6%

Revenue $1.61B; Net margin 59.6%.

• ▍Revenue $1.61B
• ▍Net margin 59.6%

Revenue $1.62B; Net margin 74.2%.

• ▍Revenue $1.62B
• ▍Net margin 74.2%

Revenue $1.62B; Net margin 74.2%.

• ▍Revenue $1.62B
• ▍Net margin 74.2%